BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9371 related articles for article (PubMed ID: 1873505)

  • 1. Hybridoma-derived human suppressor factors: inhibition of growth of tumor cell lines and effect on cytotoxic cells.
    Kunicka JE; Fox FE; Seki H; Oleszak EL; Platsoucas CD
    Hum Antibodies Hybridomas; 1991 Jul; 2(3):160-9. PubMed ID: 1873505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human suppressor factors constitutively produced by T-T cell hybridomas: functional and biochemical characterization.
    Kunicka JE; Calvelli TA; Fox FE; Steinberg J; Telerman A; Platsoucas C
    Hybridoma; 1989 Apr; 8(2):127-51. PubMed ID: 2785481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human hybridoma-derived suppressor factor 160 and transforming growth factor-beta are different molecules.
    Fox FE; Oleszak EL; Chen PF; Platsoucas CD
    Lymphokine Cytokine Res; 1992 Dec; 11(6):307-15. PubMed ID: 1477184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological properties of suppressive E-receptor factor on lymphokine function.
    Oh SK; Leung MF; Knee T; Williams JM
    Eur J Immunol; 1987 Oct; 17(10):1403-9. PubMed ID: 3119348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human T-T cell hybridomas: development and applications.
    Fox FE; Platsoucas CD
    Hum Antibodies Hybridomas; 1990; 1(1):3-9. PubMed ID: 2103350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulated rat T cell-derived inhibitory factor for cellular DNA synthesis (STIF). III. Effect on cell proliferation and immune responses.
    Chiba K; Nishimura T; Hashimoto Y
    J Immunol; 1985 May; 134(5):3172-8. PubMed ID: 2580017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of cytotoxic T lymphocytes from thymocyte precursors to trinitrophenyl-modified self antigens. II. Establishment of a T cell hybrid clone constitutively producing killer-helper factor(s) (KHF) and functional analysis of released KHF.
    Kikuchi Y; Kato R; Sano Y; Takahashi H; Kanatani T; Takatsu K
    J Immunol; 1986 May; 136(10):3553-60. PubMed ID: 2939132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limiting dilution analysis of the frequency of human T cells and large granular lymphocytes proliferating in response to interleukin 2. I. The effect of lectin on the proliferative frequency and cytotoxic activity of cultured lymphoid cells.
    Vose BM; Bonnard GD
    J Immunol; 1983 Feb; 130(2):687-93. PubMed ID: 6600251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.
    Fujiwara H; Toossi Z; Ohnishi K; Edmonds K; Ellner JJ
    J Immunol; 1987 Jan; 138(1):197-203. PubMed ID: 3097146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A T-helper cell x Molt4 human hybridoma constitutively producing B-cell stimulatory and inhibitory factors.
    Rosén A; Uggla C; Szigeti R; Kallin B; Lindqvist C; Zeuthen J
    Lymphokine Res; 1986; 5(3):185-204. PubMed ID: 2943947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a human T cell hybridoma cell line producing suppressor factor specific for anti-thyroglobulin antibody production.
    Noma T; Yata J
    J Immunol; 1987 May; 138(9):2929-34. PubMed ID: 3494775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new method for the development of human T-T cell hybrids without the use of HAT medium.
    Platsoucas CD; Calvelli TA; Kunicka JA
    Hybridoma; 1987 Dec; 6(6):589-603. PubMed ID: 3501764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
    Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
    Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB; Gutterman JU; Grimm EA
    Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell lines derived from human autorosette-forming cells with suppressive activity.
    Michlin H; Schlesinger M; Kalechman Y; Sredni B
    Nat Immun Cell Growth Regul; 1990; 9(1):49-59. PubMed ID: 2139496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accessory function of human fibroblasts in mitogen-stimulated interferon-gamma production by T lymphocytes. Inhibition by interleukin 1 and tumor necrosis factor.
    Le JM; Vilcek J
    J Immunol; 1987 Nov; 139(10):3330-7. PubMed ID: 3119705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of B cell maturation and differentiation. I. Suppression of pokeweed mitogen-induced B cell differentiation by tumor necrosis factor (TNF).
    Kashiwa H; Wright SC; Bonavida B
    J Immunol; 1987 Mar; 138(5):1383-90. PubMed ID: 2949015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 469.